Evidence map›Paper›PMID 22373577›Full record

ArticleThe EMBO journal2012

Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases.

Timothy P Wakeman, Qinhong Wang, Junjie Feng, Xiao-Fan Wang

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Discovery of the first-in-class DOT1L PROTAC degrader.European journal of medicinal chemistry · 2025
    Article
  6. Article
  7. DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Timothy P WakemanDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.
Qinhong Wang
Junjie Feng
Xiao-Fan Wang
Duke Medical Center · USDuke University Hospital · US

Funding

Rad17 - & p53-mediated apoptosis pathways in response to DNA damageR01CA123250 · NCI · DUKE UNIVERSITY · PI WANG, XIAO-FAN · 2006 to 2010
$1.4M
NCI NIH HHS R01 CA123250
6 · The paper itself

Abstract

The methyltransferase DOT1L methylates histone H3 at K79 to facilitate specific biological events. H3K79 dimethylation (H3K79-2Me) by DOT1L influences the DNA damage response by promoting 53BP1 recruitment to DNA damage sites; however, it is unclear if this methylation is required as 53BP1 interacts with dimethylated H4 (H4K20-2Me) with a much higher affinity. We demonstrate that H3K79-2Me, while negligible during S-phase, is required for ionizing radiation (IR)-induced 53BP1 foci formation during G1/G2-phases when H4K20-2Me levels are low. Further, we describe an essential role for HLA-B-associated transcript 3 (Bat3) in regulating this process in U2OS cells. Bat3 co-localizes with DOT1L at histone H3, and Bat3 knockdown results in decreased DOT1L-H3 interaction and H3K79-2Me, leading to a reduction in IR-induced 53BP1 foci formation, defects in DNA repair and increased sensitivity to IR. We demonstrate that a conserved Bat3 ubiquitin-like motif and a conserved DOT1L ubiquitin-interacting motif promote DOT1L-Bat3 interaction to facilitate efficient H3K79-2Me and IR-induced 53BP1 foci formation during G1/G2-phases. Taken together, our findings identify a novel role for Bat3 in regulating DOT1L function, which plays a critical role in DNA damage response.

Indexed as

DNA DamageCell Line, TumorDNA RepairG1 PhaseG2 PhaseHEK293 CellsHeLa CellsHistone-Lysine N-MethyltransferaseHistonesHumansIntracellular Signaling Peptides and ProteinsMethylationMethyltransferasesMolecular ChaperonesTumor Suppressor p53-Binding Protein 1BAG6 protein, humanDOT1L protein, humanHistone-Lysine N-MethyltransferaseHistonesIntracellular Signaling Peptides and ProteinsMethyltransferasesMolecular ChaperonesTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID22373577
PMCPMC3343460
OpenAlexW2116860088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.